Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury

Journal of Bone and Mineral Research

Volumn 29, Issue 1, 2014, Pages 251-259

  Doherty, Ashley L ^a   Battaglino, Ricardo A ^b,c   Donovan, Jayne ^a   Gagnon, David ^d   Lazzari, Antonio A ^e   Garshick, Eric ^f,g   Zafonte, Ross ^a,g   Morse, Leslie R ^a,b,g  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^b FORSYTH INSTITUTE   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VA BOSTON HEALTHCARE SYSTEM   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adiponectin; biomarker; Osteoporosis; rehabilitation medicine; spinal cord injury

Indexed keywords

ADIPONECTIN; LEPTIN; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; CHRONIC DISEASE; CONTROLLED STUDY; FRAGILITY FRACTURE; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; SPINAL CORD INJURY; VERY ELDERLY; WALKER; WALKING; WHEELCHAIR;

ADIPONECTIN; BIOMARKER; OSTEOPOROSIS; REHABILITATION MEDICINE; SPINAL CORD INJURY;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONES OF LOWER EXTREMITY; HUMANS; LEPTIN; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SPINAL CORD INJURIES; WALKING; WHEELCHAIRS;

EID: 84890940958     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2020     Document Type: Article

References (59)

1. Duque G., Bone and fat connection in aging bone. Curr Opin Rheumatol. 2008; 20: 429-34.
2. Rosen CJ, Klibanski A., Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med. 2009; 122: 409-14.
3. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE., Adiponectin and its receptors are expressed in bone-forming cells. Bone. 2004; 35: 842-9.
4. Cornish J, Callon KE, Bava U, Lin C, Naot D, Hill BL, Grey AB, Broom N, Myers DE, Nicholson GC, Reid IR., Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002; 175: 405-15.
5. Guo LJ, Xie H, Liao EY., [Effect of adiponectin on human osteoblast differentiation]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008; 33: 731-6. Chinese
6. Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Kajimura D, Myers MG Jr, Chua SC Jr, Wang Q, Kim JK, Kaestner KH, Karsenty G., An osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Ann N Y Acad Sci. 2009; 1173 (Suppl 1): E20-30.
7. Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC., Leptin inhibits osteoclast generation. J Bone Miner Res. 2002; 17: 200-9.
8. Lee HW, Kim SY, Kim AY, Lee EJ, Choi JY, Kim JB., Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells. 2009; 27: 2254-62.
9. Lee WY, Rhee EJ, Oh KW, Kim SY, Jung CH, Yun EJ, Baek KH, Kang MI, Kim SW., Identification of adiponectin and its receptors in human osteoblast-like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women. Clin Endocrinol (Oxf). 2006; 65: 631-7.
10. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I., Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun. 2005; 331: 520-6.
11. Peng M, Chen S, Fang W, Yu X., Effects of leptin on the expression of alpha1 (I) collagen gene in human osteoblast-like MG63 cells. Biochem Cell Biol. 2010; 88: 683-6.
12. Zeadin MG, Butcher MK, Shaughnessy SG, Werstuck GH., Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3beta. Biochem Biophys Res Commun. 2012; 425: 924-30.
13. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM., Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab. 2011; 96: E1982-9.
14. Zhang Y, Zhou P, Kimondo JW., Adiponectin and osteocalcin: relation to insulin sensitivity. Biochem Cell Biol. 2012; 90: 613-20.
15. Ealey KN, Kaludjerovic J, Archer MC, Ward WE., Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood). 2008; 233: 1546-53.
16. Adiponectin is a metabolic link between obesity and bone mineral density. Exp Biol Med (Maywood). 2008; 233: vi.
17. Aǧbaht K, Gürlek A, Karakaya J, Bayraktar M., Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. Endocrine. 2009 Jun; 35 (3): 371-9. doi: 10.1007/s12020-009- 9158-2
18. Basurto L, Galvan R, Cordova N, Saucedo R, Vargas C, Campos S, Halley E, Avelar F, Zarate A., Adiponectin is associated with low bone mineral density in elderly men. Eur J Endocrinol. 2009; 160: 289-93.
19. Dennison EM, Syddall HE, Fall CH, Javaid MK, Arden NK, Phillips DI, Cooper C., Plasma leptin concentration and change in bone density among elderly men and women: the Hertfordshire Cohort Study. Calcif Tissue Int. 2004; 74: 401-6.
20. Huang KC, Cheng WC, Yen RF, Tsai KS, Tai TY, Yang WS., Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents. Clin Endocrinol (Oxf). 2004; 61: 204-8.
21. Jen KL, Buison A, Darga L, Nelson D., The relationship between blood leptin level and bone density is specific to ethnicity and menopausal status. J Lab Clin Med. 2005; 146: 18-24.
22. Jurimae J, Kums T, Jurimae T., Adipocytokine and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations. Eur J Endocrinol. 2009; 160: 381-5.
23. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T., Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol. 2009; 160: 265-73.
24. Kaufman BA, Warren MP, Dominguez JE, Wang J, Heymsfield SB, Pierson RN., Bone density and amenorrhea in ballet dancers are related to a decreased resting metabolic rate and lower leptin levels. J Clin Endocrinol Metab. 2002; 87: 2777-83.
25. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW., Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003; 33: 646-51.
26. Muñoz MT, de la Piedra C, Barrios V, Garrido G, Argente J., Changes in bone density and bone markers in rhythmic gymnasts and ballet dancers: implications for puberty and leptin levels. Eur J Endocrinol. 2004; 151: 491-6.
27. Papadopoulou F, Krassas GE, Kalothetou C, Koliakos G, Constantinidis TC., Serum leptin values in relation to bone density and growth hormone-insulin like growth factors axis in healthy men. Arch Androl. 2004; 50: 97-103.
28. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD., Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab. 2007; 92: 1517-23.
29. Soot T, Jurimae T, Jurimae J., Areal bone density in young females with different physical activity patterns: relationships with plasma leptin and body composition. J Sports Med Phys Fitness. 2007; 47: 65-9.
30. Ushiroyama T, Ikeda A, Hosotani T, Higashiyama T, Ueki M., Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol. 2003; 17: 31-6.
31. Zoico E, Zamboni M, Di Francesco V, Mazzali G, Fantin F, De Pergola G, Zivelonghi A, Adami S, Bosello O., Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest. 2008; 31: 297-302.
32. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G., Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002; 111: 305-17.
33. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G., Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100: 197-207.
34. Khosla S., Leptin-central or peripheral to the regulation of bone metabolism ? Endocrinology. 2002; 143: 4161-4.
35. Turner RT, Kalra SP, Wong CP, Philbrick KA, Lindenmaier LB, Boghossian S, Iwaniec UT., Peripheral leptin regulates bone formation. J Bone Miner Res. 2013; 28: 22-34.
36. Enjuanes A, Supervia A, Nogues X, Diez-Perez A., Leptin receptor (OB-R) gene expression in human primary osteoblasts: confirmation. J Bone Miner Res. 2002; 17: 1135.
37. Thomas T., Leptin: a potential mediator for protective effects of fat mass on bone tissue. Joint Bone Spine. 2003; 70: 18-1821.
38. Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW., Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest. 2002; 109: 1303-10.
39. Johansson H, Oden A, Lerner UH, Jutberger H, Lorentzon M, Barrett-Connor E, Karlsson MK, Ljunggren O, Smith U, McCloskey E, Kanis JA, Ohlsson C, Mellstrom D., High serum adiponectin predicts incident fractures in elderly men: Osteoporotic Fractures in Men (MrOS) Sweden. J Bone Miner Res. 2012; 27: 1390-6.
40. Araneta MR, von Mühlen D, Barrett-Connor E., Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res. 2009; 24: 2016-22.
41. Barbour KE, Zmuda JM, Boudreau R, Strotmeyer ES, Horwitz MJ, Evans RW, Kanaya AM, Harris TB, Bauer DC, Cauley JA., Adipokines and the risk of fracture in older adults. J Bone Miner Res. 2011; 26: 1568-76.
42. Felson DT, Zhang Y, Hannan MT, Anderson JJ., Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993; 8: 567-73.
43. Reid IR., Relationships among body mass, its components, and bone. Bone. 2002; 31: 547-55.
44. Battaglino RA, Sudhakar S, Lazzari AA, Garshick E, Zafonte R, Morse LR., Circulating sclerostin is elevated in short-term and reduced in long-term SCI. Bone. 2012; 51: 600-5.
45. Morse LR, Sudhakar S, Danilack V, Tun C, Lazzari A, Gagnon DR, Garshick E, Battaglino RA., Association between sclerostin and bone density in chronic spinal cord injury. J Bone Miner Res. 2012; 27: 352-9.
46. Morse LR, Lazzari AA, Battaglino R, Stolzmann KL, Matthess KR, Gagnon DR, Davis SA, Garshick E., Dual energy X-ray absorptiometry of the distal femur may be more reliable than the proximal tibia in spinal cord injury. Arch Phys Med Rehabil. 2009; 90: 827-31.
47. Iacobellis G, Iorio M, Napoli N, Cotesta D, Zinnamosca L, Marinelli C, Petramala L, Minisola S, D'Erasmo E, Letizia C., Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. J Endocrinol Invest. 2011; 34: e12-5.
48. Jurimae J, Jurimae T, Leppik A, Kums T., The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab. 2008; 26: 618-23.
49. Spungen AM, Adkins RH, Stewart CA, Wang J, Pierson RN Jr, Waters RL, Bauman WA., Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol. 2003; 95: 2398-407.
50. Gater DR, Kody CL., Body composition assessment in spinal cord injury clinical trials. Top Spinal Cord Inj Rehabil. 2005; 11: 36-49.
51. Petit MA, Beck TJ, Hughes JM, Lin HM, Bentley C, Lloyd T., Proximal femur mechanical adaptation to weight gain in late adolescence: a six-year longitudinal study. J Bone Miner Res. 2008; 23: 180-8.
52. Raska I Jr, Broulik P., The impact of diabetes mellitus on skeletal health: an established phenomenon with in established causes ? Prague Med Rep. 2005; 106: 137-48.
53. Bauman WA, Spungen AM, Zhong YG, Mobbs CV., Plasma leptin is directly related to body adiposity in subjects with spinal cord injury. Horm Metab Res. 1996; 28: 732-6.
54. Gezici AR, Ergun R, Karakas A, Gunduz B., Serum leptin levels following acute experimental spinal cord injury. J Spinal Cord Med. 2009; 32: 416-21.
55. Huang TS, Wang YH, Chen SY., The relation of serum leptin to body mass index and to serum cortisol in men with spinal cord injury. Arch Phys Med Rehabil. 2000; 81: 1582-6.
56. Jeon JY, Steadward RD, Wheeler GD, Bell G, McCargar L, Harber V., Intact sympathetic nervous system is required for leptin effects on resting metabolic rate in people with spinal cord injury. J Clin Endocrinol Metab. 2003; 88: 402-7.
57. Maimoun L, Puech AM, Manetta J, Badiou S, Paris F, Ohanna F, Rossi M, Sultan C., Circulating leptin concentrations can be used as a surrogate marker of fat mass in acute spinal cord injury patients. Metabolism. 2004; 53: 989-94.
58. Maruyama Y, Mizuguchi M, Yaginuma T, Kusaka M, Yoshida H, Yokoyama K, Kasahara Y, Hosoya T., Serum leptin, abdominal obesity and the metabolic syndrome in individuals with chronic spinal cord injury. Spinal Cord. 2008; 46: 494-9.
59. Wang YH, Huang TS, Liang HW, Su TC, Chen SY, Wang TD., Fasting serum levels of adiponectin, ghrelin, and leptin in men with spinal cord injury. Arch Phys Med Rehabil. 2005; 86: 1964-8.